GAMMA Investing’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.22M Buy
1,952
+794
+69% +$465K 0.04% 362
2026
Q2
$613K Buy
1,158
+32
+3% +$14.8K 0.02% 565
2026
Q1
$541K Buy
1,126
+254
+29% +$130K 0.03% 544
2025
Q4
$490K Buy
872
+125
+17% +$71K 0.02% 539
2025
Q3
$384K Buy
747
+226
+43% +$98.7K 0.02% 604
2025
Q2
$164K Buy
521
+214
+70% +$64.2K 0.01% 1050
2025
Q1
$93.5K Buy
307
+83
+37% +$27.9K 0.01% 1315
2024
Q4
$74.4K Buy
224
+13
+6% +$4.41K 0.01% 1336
2024
Q3
$70.4K Sell
211
-25
-11% -$9.5K 0.01% 1243
2024
Q2
$97.2K Buy
236
+87
+58% +$34.5K 0.01% 797
2024
Q1
$60.2K Buy
149
+45
+43% +$15.8K 0.01% 915
2023
Q4
$30.3K Buy
+104
New +$28.1K 0.01% 1222

Other funds holding MEDP

GAMMA Investing's MEDP Position: Q3 2026 in Review

GAMMA Investing increased its Medpace (MEDP) stake by 69% in Q3 2026, buying an estimated $465K and bringing the position to 1,952 shares worth $1.22M. The position accounts for 0.04% of the portfolio, ranked #362.

GAMMA Investing first reported a position in MEDP in Q4 2023 and has held it in 12 quarters since. 22 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.

  • GAMMA Investing held 1,952 shares of Medpace worth $1.22M as of Q3 2026.
  • GAMMA Investing bought 794 Medpace shares in Q3 2026, an estimated $465K.
  • Medpace made up 0.04% of GAMMA Investing's portfolio in Q3 2026, its #362 holding.
  • GAMMA Investing first reported a position in Medpace in Q4 2023 and has held it in 12 quarters since.
  • 22 funds tracked by Wall St. Rank held Medpace as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.